secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000950170-22-021909
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q3 revenue $57.4M (+33% YoY); net loss narrows; appoints Jon Maack as President
--------------------------------------------------------------------------------

- Revenue $57.4M (+33% YoY), net loss $6.4M vs $21.0M; adjusted EBITDA $16.4M (29% revenue).
- Q4 revenue guidance $58-59M (median +26% YoY); full-year 2022 revenue guidance $220-221M.
- Jon Maack appointed President, effective Nov 3, 2022; reports to CEO; oversees product, engineering, strategy, M&A.
- Maack received $400k base salary, 70% bonus target, 546k RSUs; previously Chief Strategy Officer at athenahealth.
- Unlevered free cash flow $15.5M (27% revenue) in Q3; trailing twelve-month $67.4M (32% revenue).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017022021909/0000950170-22-021909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017022021909/dh-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-021909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer